Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gregory

Showing results (841-850 of 930) with videos related to

Pageof 93
Sort By:
Blood|June 10, 2011
Cyclophosphamide, thalidomide, and dexamethasone (CTD) as initial therapy for patients with multiple myeloma unsuitable for autologous transplantationGareth J Morgan, Faith E Davies, Walter M Gregory, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 4, 2022
Minimal Residual Disease After Autologous Stem-Cell Transplant for Patients With Myeloma: Prognostic Significance and the Impact of Lenalidomide Maintenance and Molecular RiskRuth M de Tute, Charlotte Pawlyn, David A Cairns, et al.
Frontiers in Neurology|December 26, 2024
Musculoskeletal and body composition response to high-dose testosterone with finasteride after chronic incomplete spinal cord injury-a randomized, double-blind, and placebo-controlled pilot studyDana M Otzel, Larissa Nichols, Christine F Conover, et al.
International Journal for Parasitology|November 1, 1996
Eprinomectin: a novel avermectin for use as a topical endectocide for cattleW L Shoop, J R Egerton, C H Eary, et al.
Journal of Neurotrauma|January 1, 2014
Testosterone dose dependently prevents bone and muscle loss in rodents after spinal cord injuryJoshua F Yarrow, Christine F Conover, Luke A Beggs, et al.
The Lancet. Oncology|July 21, 2011
Effects of zoledronic acid versus clodronic acid on skeletal morbidity in patients with newly diagnosed multiple myeloma (MRC Myeloma IX): secondary outcomes from a randomised controlled trialGareth J Morgan, J Anthony Child, Walter M Gregory, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 28, 2019
Overcoming anti-PEG antibody mediated accelerated blood clearance of PEGylated liposomes by pre-infusion with high molecular weight free PEGMorgan D McSweeney, Lauren S L Price, Timothy Wessler, et al.
EMBO Molecular Medicine|October 30, 2019
4'-Phosphopantetheine corrects CoA, iron, and dopamine metabolic defects in mammalian models of PKANSuh Young Jeong, Penelope Hogarth, Andrew Placzek, et al.
Medrxiv : the Preprint Server for Health Sciences|June 30, 2025
FUS Mislocalization Rewires a Cortical Gene Network to Drive Cognitive and Behavioral Impairment in ALSRaphaelle Cassel, Félicie Lorenc, Aurélie Bombardier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2019
Endogenous Production of IL1B by Breast Cancer Cells Drives Metastasis and Colonization of the Bone MicroenvironmentClaudia Tulotta, Diane V Lefley, Katy Freeman, et al.
Pageof 93

Showing results (841-850 of 930) with videos related to

Sort By:
Pageof 93
Blood|June 10, 2011
Cyclophosphamide, thalidomide, and dexamethasone (CTD) as initial therapy for patients with multiple myeloma unsuitable for autologous transplantationGareth J Morgan, Faith E Davies, Walter M Gregory, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 4, 2022
Minimal Residual Disease After Autologous Stem-Cell Transplant for Patients With Myeloma: Prognostic Significance and the Impact of Lenalidomide Maintenance and Molecular RiskRuth M de Tute, Charlotte Pawlyn, David A Cairns, et al.
Frontiers in Neurology|December 26, 2024
Musculoskeletal and body composition response to high-dose testosterone with finasteride after chronic incomplete spinal cord injury-a randomized, double-blind, and placebo-controlled pilot studyDana M Otzel, Larissa Nichols, Christine F Conover, et al.
International Journal for Parasitology|November 1, 1996
Eprinomectin: a novel avermectin for use as a topical endectocide for cattleW L Shoop, J R Egerton, C H Eary, et al.
Journal of Neurotrauma|January 1, 2014
Testosterone dose dependently prevents bone and muscle loss in rodents after spinal cord injuryJoshua F Yarrow, Christine F Conover, Luke A Beggs, et al.
The Lancet. Oncology|July 21, 2011
Effects of zoledronic acid versus clodronic acid on skeletal morbidity in patients with newly diagnosed multiple myeloma (MRC Myeloma IX): secondary outcomes from a randomised controlled trialGareth J Morgan, J Anthony Child, Walter M Gregory, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 28, 2019
Overcoming anti-PEG antibody mediated accelerated blood clearance of PEGylated liposomes by pre-infusion with high molecular weight free PEGMorgan D McSweeney, Lauren S L Price, Timothy Wessler, et al.
EMBO Molecular Medicine|October 30, 2019
4'-Phosphopantetheine corrects CoA, iron, and dopamine metabolic defects in mammalian models of PKANSuh Young Jeong, Penelope Hogarth, Andrew Placzek, et al.
Medrxiv : the Preprint Server for Health Sciences|June 30, 2025
FUS Mislocalization Rewires a Cortical Gene Network to Drive Cognitive and Behavioral Impairment in ALSRaphaelle Cassel, Félicie Lorenc, Aurélie Bombardier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2019
Endogenous Production of IL1B by Breast Cancer Cells Drives Metastasis and Colonization of the Bone MicroenvironmentClaudia Tulotta, Diane V Lefley, Katy Freeman, et al.
Pageof 93